{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:21:41Z","timestamp":1788142901104,"version":"build-2803163510"},"reference-count":82,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0212157","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T13:26:24Z","timestamp":1558704384000},"page":"e0212157","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9871-7637","authenticated-orcid":true,"given":"Linea Natalie","family":"Toksvang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus Str\u00f8h","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Arup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke Hebo","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8495-5274","authenticated-orcid":true,"given":"Thomas Leth","family":"Frandsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0829-4993","authenticated-orcid":true,"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie Utke","family":"Rank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,5,24]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-85-5-578","article-title":"Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Report of two cases","volume":"85","author":"PF Griner","year":"1976","journal-title":"Ann Intern Med"},{"issue":"9544","key":"ref2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(06)69558-5","article-title":"Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial","volume":"368","author":"A Vora","year":"2006","journal-title":"Lancet"},{"issue":"14","key":"ref3","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1182\/blood-2009-07-230656","article-title":"Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children\u2019s Oncology Group CCG-1952 clinical trial","volume":"115","author":"LC Stork","year":"2010","journal-title":"Blood"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"e26519","DOI":"10.1002\/pbc.26519","article-title":"Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites","volume":"64","author":"LN Toksvang","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/apt.12490","article-title":"Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy","volume":"38","author":"CO Musumba","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"e26495","DOI":"10.1002\/pbc.26495","article-title":"Long-term risk of portal hypertension and related complications in children treated with 6-thioguanine for acute lymphoblastic leukemia: A single-center experience","volume":"64","author":"N, M Roy Moulik","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)","volume":"22","author":"LD DeLeve","year":"2002","journal-title":"Semin Liver Dis"},{"key":"ref8","first-page":"25","article-title":"Vascular liver disease: Mechanisms and management","author":"LD DeLeve","year":"2011"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0034-1375963","article-title":"Drug-induced nodular regenerative hyperplasia","volume":"34","author":"M Ghabril","year":"2014","journal-title":"Semin Liver Dis"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/gutjnl-2012-302274","article-title":"A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity","volume":"62","author":"I Oancea","year":"2013","journal-title":"Gut"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/lt.20554","article-title":"Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity","volume":"11","author":"NK de Boer","year":"2005","journal-title":"Liver Transplant"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/leu.2011.37","article-title":"Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia","volume":"25","author":"G Escherich","year":"2011","journal-title":"Leukemia"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/14656566.2017.1340938","article-title":"Novel therapy for childhood acute lymphoblastic leukemia","volume":"18","author":"R Santiago","year":"2017","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3324\/haematol.2015.131680","article-title":"Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: Prognostic factors, treatment and outcome","volume":"101","author":"T Oskarsson","year":"2016","journal-title":"Haematologica"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0145-2126(94)90159-7","article-title":"The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia","volume":"18","author":"PC Adamson","year":"1994","journal-title":"Leuk Res"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/ncpgasthep1000","article-title":"Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD","volume":"4","author":"NK de Boer","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1470-2045(17)30154-7","article-title":"DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial","volume":"18","author":"SN Nielsen","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref18","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"J Higgins","year":"2011"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"A Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/S1470-2045(16)30035-3","article-title":"Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus","volume":"17","author":"K Schmiegelow","year":"2016","journal-title":"Lancet Oncol"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1572-0241.2007.01187.x","article-title":"Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review","volume":"102","author":"JP Gisbert","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref23","unstructured":"NIH, National Heart Lung and Blood Institute. The study quality assessment tools of the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) for quality assessment of Observational Cohort and Cross-Sectional Studies and Con [Internet]. [cited 2018 Oct 1]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/in-develop\/cardiovascular-risk-reduction\/tools\" xlink:type=\"simple\">https:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/in-develop\/cardiovascular-risk-reduction\/tools<\/ext-link>"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"MH Murad","year":"2018","journal-title":"BMJ evidence-based Med"},{"issue":"7454","key":"ref25","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"D Atkins","year":"2004","journal-title":"BMJ"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2002-08-2372","article-title":"Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: Results of the randomized trial COALL-92","volume":"102","author":"DO Harms","year":"2003","journal-title":"Blood"},{"issue":"31","key":"ref27","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1200\/JCO.2005.01.1031","article-title":"Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87","volume":"23","author":"HG Einsiedel","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/pbc.20964","article-title":"Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: A collaborative Children\u2019s Oncology Group\/National Cancer Institute pilot trial (CCG-1942)","volume":"49","author":"SS Jacobs","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1445-5994.2003.00321.x","article-title":"6-Thioguanine: A new old drug to procure remission in inflammatory bowel disease","volume":"33","author":"TK Cheung","year":"2003","journal-title":"Intern Med J"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2036.2003.01652.x","article-title":"High variation of tioguanine absorption in patients with chronic active Crohn\u2019s disease","volume":"18","author":"P Deibert","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0016-5085(03)00938-7","article-title":"6-thioguanine can cause serious liver injury in inflammatory bowel disease patients","volume":"125","author":"MC Dubinsky","year":"2003","journal-title":"Gastroenterology"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/j.1572-0241.2007.01530.x","article-title":"6-Thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension","volume":"102","author":"A Ferlitsch","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"S490","DOI":"10.14309\/00000434-200709002-01012","article-title":"Treatment of inflammatory bowel disease with 6-thioguanine (6-TG): Retrospective case series from a tertiary care center","volume":"102","author":"CP Hasyagar","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"ref34","first-page":"A630","article-title":"Efficacy of 6-thioguanine in patients with Crohn\u2019s disease intolerant to azathioprine","volume":"126","author":"D Ivastinovic","year":"2004","journal-title":"Gastroenterology"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1476-5381.2011.01265.x","article-title":"Biotransformation of 6-thioguanine in inflammatory bowel disease patients: A comparison of oral and intravenous administration of 6-thioguanine","volume":"163","author":"B Jharap","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"4","key":"ref36","first-page":"A221","article-title":"\u201cLower\u201d 6-thioguanine (6-TG) levels may be as effective as \u201chigher\u201d 6-TG levels in IBD patients treated with thioguanine","volume":"122","author":"A Kornbluth","year":"2002","journal-title":"Gastroenterology"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.0306-5251.2001.01391.x","article-title":"6-Thioguanine in children with acute lymphoblastic leukaemia: Influence of food on parent drug pharmacokinetics and 6-thioguanine nucleotide concentrations","volume":"51","author":"DL Lancaster","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"ref38","first-page":"A437","article-title":"6-Thioguanine as an alternative therapy in inflammatory bowel disease-experience in a London district general hospital","volume":"1","author":"OS Omer","year":"2015","journal-title":"United Eur Gastroenterol J"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1097\/MIB.0000000000000206","article-title":"Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study","volume":"20","author":"P Pavlidis","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/00365520600825166","article-title":"Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease","volume":"42","author":"A Qasim","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"ref41","first-page":"A526","article-title":"To evaluate the efficacy and safety of 6-thioguanine therapy in patients with inflammatory bowel disease-a London DGH experience","volume":"1","author":"R Saleem","year":"2013","journal-title":"United Eur Gastroenterol J"},{"issue":"17\u201318","key":"ref42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00508-007-0841-0","article-title":"A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease","volume":"119","author":"A Teml","year":"2007","journal-title":"Wien Klin Wochenschr"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/pbc.20128","article-title":"Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse","volume":"43","author":"B Thomson","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1097\/MIB.0000000000000869","article-title":"The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease","volume":"22","author":"DP van Asseldonk","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/2050640616663438","article-title":"Thioguanine in inflammatory bowel disease: Long-term efficacy and safety","volume":"5","author":"MG Ward","year":"2017","journal-title":"United Eur Gastroenterol J"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/pbc.25057","article-title":"TPMT and MTHFR genotype is not associated with altered risk of thioguanine-related sinusoidal obstruction syndrome in pediatric acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group","volume":"61","author":"L Wray","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"ref47","first-page":"67","article-title":"Thioguanine, pancreatotoxicity?","volume":"56","author":"D Bisschop","year":"2001","journal-title":"Therapie"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/pbc.20202","article-title":"Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy","volume":"44","author":"EH Broxson","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5114\/pg.2012.27224","article-title":"Psychosomatic complications during treatment for ulcerative colitis","volume":"1","author":"C Chojnacki","year":"2012","journal-title":"Gastroenterol Rev"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MPG.0b013e31822960e9","article-title":"Long-term follow-up of children with 6-thioguanine-related chronic hepatoxicity following treatment for acute lymphoblastic leukaemia","volume":"53","author":"D Rawat","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/ibd.20323","article-title":"Variceal hemorrhage in a patient with ulcerative colitis treated with 6-thioguanine","volume":"14","author":"E Fritz","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"ref52","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00054725-200409000-00023","article-title":"Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn\u2019s disease","volume":"10","author":"S Kane","year":"2004","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"ref53","first-page":"788","article-title":"Thioguanine treatment-related sinusoidal obstruction syndrome in 2 children","volume":"15","author":"J Mao","year":"2013","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/ajg.2016.210","article-title":"MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome","volume":"111","author":"G Marasco","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.crohns.2009.02.002","article-title":"Safe 6-thioguanine therapy of a TPMT deficient Crohn\u2019s disease patient by using therapeutic drug monitoring","volume":"3","author":"WG Mares","year":"2009","journal-title":"J Crohn\u2019s Colitis"},{"issue":"5","key":"ref56","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/08880010050034391","article-title":"Veno-occlusive disease of the liver associated with thiopurines in a child with acute lymphoblastic leukemia","volume":"17","author":"JM Merino","year":"2000","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1097\/MPH.0000000000000246","article-title":"Pharmacokinetics of 6-thioguanine and 6-mercaptopurine combination maintenance therapy of childhood ALL: Hypothesis and case report","volume":"37","author":"SN Nielsen","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"ref58","first-page":"131","article-title":"Brodzicki J. The case of colitis ulcerosa\u2014Diagnostic and therapeutic difficulties","volume":"8","author":"W. Radys","year":"2006","journal-title":"Pediatr Wspolczesna"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00004836-200303000-00010","article-title":"Hepatotoxicity associated with 6-thioguanine therapy for Crohn\u2019s disease","volume":"36","author":"SJ Rulyak","year":"2003","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"ref60","first-page":"a711","article-title":"Liver veno-occlusive disease (VOD) in a patient given 6-thioguanine for crohn\u2019s disease","volume":"7","author":"A Salerno","year":"2014","journal-title":"Br J Med Pract"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5858\/2004-128-49-ENHOTL","article-title":"Early nodular hyperplasia of the liver occurring with inflammatory bowel diseases in association with thioguanine therapy","volume":"128","author":"S Shastri","year":"2004","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"ref62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ecco-jcc\/jjv189","article-title":"Safety of Tioguanine During Pregnancy in Inflammatory Bowel Disease","volume":"10","author":"SA Van den Berg","year":"2016","journal-title":"J Crohns Colitis"},{"issue":"6","key":"ref63","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1572-0241.2004.30292.x","article-title":"Thioguanine-induced symptomatic thrombocytopenia","volume":"99","author":"HH Wenzl","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"ref64","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2036.2005.02581.x","article-title":"On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment","volume":"22","author":"NK de Boer","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"ref65","first-page":"99","article-title":"Thioguanine use in inflammatory bowel disease: 13 year experience in a tertiary centre","volume":"2","author":"MG Ward","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"ref66","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update","author":"M V Relling","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1258\/0004563041201455","article-title":"Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy","volume":"41","author":"J Sanderson","year":"2004","journal-title":"Ann Clin Biochem"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbrc.2013.06.067","article-title":"Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells","volume":"437","author":"H Karim","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"ref69","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3508","article-title":"NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity","volume":"48","author":"T Moriyama","year":"2016","journal-title":"Nat Genet"},{"issue":"12","key":"ref70","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2174\/138945006779025446","article-title":"Ethnic Differences in Pharmacogenetically Relevant Genes","volume":"7","author":"R Engen","year":"2006","journal-title":"Curr Drug Targets"},{"issue":"4","key":"ref71","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.clpt.2006.07.002","article-title":"The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia","volume":"80","author":"L Lennard","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"ref72","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2141.2003.04578.x","article-title":"Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia","volume":"123","author":"S Stoneham","year":"2003","journal-title":"Br J Haematol"},{"issue":"2","key":"ref73","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.dld.2006.10.007","article-title":"Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects","volume":"39","author":"LPL Gilissen","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"1","key":"ref74","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.dld.2017.09.128","article-title":"Transient elastography to assess liver stiffness in patients with inflammatory bowel disease","volume":"50","author":"B Meijer","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"9","key":"ref75","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.pas.0000128665.12063.97","article-title":"Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease","volume":"28","author":"SA Geller","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"ref76","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/00365520701800266","article-title":"Histopathology of liver biopsies from a thiopurine-na\u00efve inflammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia","volume":"43","author":"NK de Boer","year":"2008","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"ref77","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transpormation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules","volume":"11","author":"IR Wanless","year":"1990","journal-title":"Hepatology"},{"issue":"1","key":"ref78","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000091662","article-title":"6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party","volume":"73","author":"NK de Boer","year":"2006","journal-title":"Digestion"},{"issue":"2","key":"ref79","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2005.02.051","article-title":"A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine","volume":"43","author":"J Seiderer","year":"2005","journal-title":"J Hepatol"},{"issue":"5","key":"ref80","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/01.mpg.0000221901.76404.07","article-title":"6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia\u2014A dual-centre experience","volume":"42","author":"M Ravikumara","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"ref81","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3748\/wjg.v17.i11.1400","article-title":"Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension","volume":"17","author":"M Hartleb","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"5","key":"ref82","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/2050640616680550","article-title":"Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units","volume":"5","author":"B Meijer","year":"2017","journal-title":"United Eur Gastroenterol J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0212157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T12:27:44Z","timestamp":1663504064000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0212157"}},"subtitle":[],"editor":[{"given":"Obul Reddy","family":"Bandapalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":82,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0212157","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/535518","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.17504\/protocols.io.zjnf4me","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,24]]}}}